The National Agency for Food and Drug Administration and Control has announced the approval of Pfizer-BionTech COVID-19 vaccine for emergency use in Nigeria. The announcement was made at the agency headquarters in Lagos on Friday by NAFDAC Director-General, Prof Mojisola Adeyeye. “They were reviewed carefully by the NAFDAC staff COVID-19 vaccine committee to make sure that the science behind the development is well understood and in accord with our world regulatory activities. We used reliance, meaning that a more mature regulatory agency across the globe, we can use that as a basis for our review. The West African country commenced its vaccination programme against the novel coronavirus last month with 3.924m doses of AstraZeneca vaccine doses.

Source: Punch April 30, 2021 14:53 UTC